Stay updated with breaking news from Cell Tracking. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Toxys, Leiden University and Leiden University Medical Center have agreed to commercialize and further develop the ToxProfiler technology invented at the two institutions.
Toxys will immediately commercialize and develop further the in vitro reporter technology for mechanistic toxicity testing to improve the human safety assessment of novel medicines, chemicals and cosmetic ingredients. LEIDEN, The Netherlands, January 28, 2021 / B3C newswire / --Toxys, Leiden University and Leiden University Medical Center have agreed immediately to commercialize and also develop further the ToxProfiler technology invented at the two institutions. ToxProfiler allows for rapid toxicity hazard identification of novel and existing drugs, chemicals, and other substances. Furthe...